RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vitaspring Biomedical Co. Stock

Vitaspring Biomedical Co. P/E 2024

Vitaspring Biomedical Co. P/E

2.43

Ticker

VSBC

ISIN

US92851B1026

As of Dec 19, 2024, Vitaspring Biomedical Co.'s P/E ratio was 2.43, a -203.85% change from the -2.34 P/E ratio recorded in the previous year.

The Vitaspring Biomedical Co. P/E history

Vitaspring Biomedical Co. Aktienanalyse

What does Vitaspring Biomedical Co. do?

Vitaspring Biomedical Co. Ltd is a leading biomedical research and development company founded in Shanghai, China in 2001. The company specializes in the manufacturing and marketing of innovative medical technologies, biocomponents, and related services. It has become a significant partner and supplier for both domestic and international customers due to the high quality and reliability of its products and services. The company's unique business model is based on environmental and health topics, focusing on the areas of life sciences and biotechnology. Vitaspring Biomedical aims to develop products and services that can provide real benefits to humanity based on medical and scientific foundations. The hope is that all the company's future products and services will contribute to sustainably improving the quality of people's lives worldwide. Vitaspring Biomedical was founded by Dr. Yanfeng Bi in Shanghai, who is also the current CEO of the company. Dr. Bi has a strong background in biomedicine, psychology, and immunology. He emphasizes the importance of understanding people's needs and finding solutions that can truly make a difference. The company is divided into two main divisions: Life Science and Medical Equipment. The Life Science division consists of two subgroups: a) Biocomponents: This subgroup includes products related to biochemistry, molecular biology, and immunology. Vitaspring Biomedical produces a variety of biological reagents such as antibodies, proteins, enzymes, and allelotyping systems for scientific research laboratories. The products in this group have a wide range of applications in basic research, drug development, food control, and clinical diagnosis. b) Biomedical services: These services include customized and specialized services for life science research institutions and companies. This includes biostatistics, data management, bioinformatics, cell therapy services, and human experiment monitoring services. The Medical Equipment division offers equipment solutions for research, clinical diagnosis, and therapy. The products in this division include specialized facilities for clinical research and diagnosis, skincare devices, and endoscopy equipment. Vitaspring Biomedical's product portfolio mainly consists of specialized and customized applications for laboratory equipment, diagnostic equipment, and consumables for professional users. Some of the key products include antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Overall, Vitaspring Biomedical Co. Ltd is a reputable company in the biomedical industry based in Shanghai, China. It focuses on researching, developing, and manufacturing innovative and high-quality products and services in the field of life sciences and medical technology. The company's various divisions include biocomponents, biomedical services, and medical equipment. Its extensive product range includes antibodies, proteins, blood glucose meters, endoscopy devices, and skincare products. Vitaspring Biomedical Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Vitaspring Biomedical Co.'s P/E Ratio

The Price to Earnings (P/E) Ratio of Vitaspring Biomedical Co. is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Vitaspring Biomedical Co.'s P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Vitaspring Biomedical Co. is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Vitaspring Biomedical Co.’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Vitaspring Biomedical Co. stock

What is the price-to-earnings ratio of Vitaspring Biomedical Co.?

The price-earnings ratio of Vitaspring Biomedical Co. is currently 2.43.

How has the price-earnings ratio of Vitaspring Biomedical Co. changed compared to last year?

The price-to-earnings ratio of Vitaspring Biomedical Co. has increased by -203.85% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Vitaspring Biomedical Co. high compared to other companies?

Yes, the price-to-earnings ratio of Vitaspring Biomedical Co. is high compared to other companies.

How does an increase in the price-earnings ratio of Vitaspring Biomedical Co. affect the company?

An increase in the price-earnings ratio of Vitaspring Biomedical Co. would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Vitaspring Biomedical Co. affect the company?

A decrease in the price-earnings ratio of Vitaspring Biomedical Co. would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Vitaspring Biomedical Co.?

Some factors that influence the price-earnings ratio of Vitaspring Biomedical Co. are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Vitaspring Biomedical Co. pay?

Over the past 12 months, Vitaspring Biomedical Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vitaspring Biomedical Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of Vitaspring Biomedical Co.?

The current dividend yield of Vitaspring Biomedical Co. is .

When does Vitaspring Biomedical Co. pay dividends?

Vitaspring Biomedical Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vitaspring Biomedical Co.?

Vitaspring Biomedical Co. paid dividends every year for the past 0 years.

What is the dividend of Vitaspring Biomedical Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vitaspring Biomedical Co. located?

Vitaspring Biomedical Co. is assigned to the '-' sector.

Wann musste ich die Aktien von Vitaspring Biomedical Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vitaspring Biomedical Co. from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Vitaspring Biomedical Co. pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Vitaspring Biomedical Co. in the year 2023?

In the year 2023, Vitaspring Biomedical Co. distributed 0 USD as dividends.

In which currency does Vitaspring Biomedical Co. pay out the dividend?

The dividends of Vitaspring Biomedical Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vitaspring Biomedical Co.

Our stock analysis for Vitaspring Biomedical Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitaspring Biomedical Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.